×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Organovo Holdings Inc. (ONVO) NASDAQ

$0.84 (0.03) (-2.90%)

Market Cap: $12.43M

As of 06/20/24 04:00 PM EDT. Market closed.

(ONVO)

Organovo Holdings Inc. (ONVO)
NASDAQ

$0.84
(0.03) (-2.90%)

Market Cap: $12.43M

As of 06/20/24 04:00 PM EDT. Market closed.

Add to Portfolio

organovo (nyse mkt: onvo) designs and creates functional, three-dimensional human tissues for medical research and therapeutic applications. the company is collaborating with pharmaceutical and academic partners to develop human biological disease models in three dimensions. these 3d human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO Compensation (Base)
$471,154
CEO Compensation (Total)
$4.59M
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
43
CEO Compensation (Base)
$471,154
CEO Compensation (Total)
$4.59M
Address
.
PRICE CHART FOR ORGANOVO HOLDINGS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$0.87
Days Range
$0.84 - $0.88
52 week range
$0.85 - $2.05
Volume
57,683
Avg. Volume (30 days)
128,840
Market Cap
$12.43M
Dividend Yield
-
P/E
-
Shares Outstanding
14,371,826
Open
-
Previous Close
$0.87
Days Range
$0.84 - $0.88
52 week range
$0.85 - $2.05
Volume
57,683
Avg. Volume (30 days)
128,840
Market Cap
$12.43M
Dividend Yield
-
P/E
-
Shares Outstanding
14,371,826
FINANCIAL STATEMENTS FOR ORGANOVO HOLDINGS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ORGANOVO HOLDINGS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Gobel DavidDirectorNov 15, 2023 Sale$1.6219,60731,7500Nov 17, 2023, 06:34 PM
Cohen Douglas JayDirectorAug 17, 2021 Buy$6.741,0006,7381,000Aug 19, 2021, 04:05 PM
Cohen Douglas JayDirectorAug 17, 2021 Buy$6.728,75058,83910,000Aug 19, 2021, 04:05 PM
Cohen Douglas JayDirectorAug 17, 2021 Buy$6.721,0006,7201,000Aug 19, 2021, 04:05 PM
KUSSMAN CRAIGChief Financial OfficerAug 18, 2020 Option Exercise$0.5715,7008,936221,743Aug 18, 2020, 06:25 PM
CROUCH TAYLORCEO & PresidentAug 18, 2020 Option Exercise$0.575,5103,136125,144Aug 18, 2020, 06:23 PM
Bush JenniferGeneral Counsel & SecretaryAug 18, 2020 Option Exercise$0.5710,9006,204192,758Aug 18, 2020, 06:21 PM
KUSSMAN CRAIGChief Financial OfficerMay 18, 2020 Option Exercise$0.5118,0309,253237,443May 20, 2020, 06:28 PM
CROUCH TAYLORCEO & PresidentMay 18, 2020 Option Exercise$0.516,3403,254130,654May 20, 2020, 06:25 PM
Bush JenniferGeneral Counsel & SecretaryMay 18, 2020 Option Exercise$0.5114,6307,508203,658May 20, 2020, 06:22 PM
KUSSMAN CRAIGChief Financial OfficerFeb 19, 2020 Option Exercise$0.3217,1005,462255,473Feb 20, 2020, 07:28 PM
CROUCH TAYLORCEO & PresidentFeb 19, 2020 Option Exercise$0.326,0451,931136,994Feb 20, 2020, 07:26 PM
Bush JenniferGeneral Counsel & SecretaryFeb 19, 2020 Option Exercise$0.3213,8504,424218,288Feb 20, 2020, 07:25 PM
KUSSMAN CRAIGChief Financial OfficerNov 18, 2019 Option Exercise$0.4514,4106,474272,573Nov 19, 2019, 05:23 PM
CROUCH TAYLORCEO & PresidentNov 18, 2019 Option Exercise$0.455,0752,280143,039Nov 19, 2019, 05:22 PM
Bush JenniferGeneral Counsel & SecretaryNov 18, 2019 Option Exercise$0.4511,6955,255232,138Nov 19, 2019, 05:20 PM
KUSSMAN CRAIGChief Financial OfficerAug 16, 2019 Option Exercise$0.2914,7504,213286,983Aug 19, 2019, 06:23 PM
Hughes Steven GeorgeChief Medical OfficerAug 16, 2019 Sale$0.2922,2306,431138,484Aug 19, 2019, 06:22 PM
Gallant PaulGeneral ManagerAug 16, 2019 Option Exercise$0.299,5002,713191,335Aug 19, 2019, 06:21 PM
CROUCH TAYLORCEO & PresidentAug 16, 2019 Option Exercise$0.295,3001,514148,114Aug 19, 2019, 06:20 PM
Bush JenniferGeneral Counsel & SecretaryAug 16, 2019 Option Exercise$0.2911,9603,416243,833Aug 19, 2019, 06:18 PM
KUSSMAN CRAIGChief Financial OfficerMay 16, 2019 Option Exercise$0.9715,15514,700301,733May 20, 2019, 05:46 PM
Gallant PaulGeneral ManagerMay 16, 2019 Option Exercise$0.979,2748,996200,835May 20, 2019, 05:45 PM
CROUCH TAYLORCEO & PresidentMay 16, 2019 Option Exercise$0.975,4655,301153,414May 20, 2019, 05:43 PM
Bush JenniferGeneral Counsel & SecretaryMay 16, 2019 Option Exercise$0.9712,27511,907255,793May 20, 2019, 05:42 PM
KUSSMAN CRAIGChief Financial OfficerFeb 19, 2019 Option Exercise$1.0716,21517,280316,888Feb 21, 2019, 05:55 PM
Gallant PaulGeneral ManagerFeb 19, 2019 Option Exercise$1.0710,41011,094210,109Feb 21, 2019, 05:54 PM
CROUCH TAYLORCEO & PresidentFeb 19, 2019 Option Exercise$1.075,6656,037158,879Feb 21, 2019, 05:53 PM
Bush JenniferGeneral Counsel & SecretaryFeb 19, 2019 Option Exercise$1.0713,52014,408268,068Feb 21, 2019, 05:52 PM
Presnell Sharon CollinsChief Scientific OfficerNov 16, 2018 Option Exercise$1.0711,20011,954280,993Nov 20, 2018, 05:48 PM
KUSSMAN CRAIGChief Financial OfficerNov 16, 2018 Option Exercise$1.0714,72015,711333,103Nov 20, 2018, 05:46 PM
Gallant PaulGeneral ManagerNov 16, 2018 Option Exercise$1.079,45010,086220,519Nov 20, 2018, 05:45 PM
CROUCH TAYLORCEO & PresidentNov 16, 2018 Option Exercise$1.075,1405,486164,544Nov 20, 2018, 05:42 PM
Bush JenniferGeneral Counsel & SecretaryNov 16, 2018 Option Exercise$1.0711,91512,717281,588Nov 20, 2018, 05:40 PM
Presnell Sharon CollinsChief Scientific OfficerNov 08, 2018 Sale$1.2740,00050,800292,193Nov 13, 2018, 05:17 PM
Presnell Sharon CollinsChief Scientific OfficerAug 16, 2018 Option Exercise$1.1111,65512,908332,193Aug 16, 2018, 07:03 PM
KUSSMAN CRAIGChief Financial OfficerAug 16, 2018 Option Exercise$1.1115,32016,967347,823Aug 16, 2018, 07:02 PM
Gallant PaulGeneral ManagerAug 16, 2018 Option Exercise$1.119,83510,892229,969Aug 16, 2018, 07:01 PM
CROUCH TAYLORCEO & PresidentAug 16, 2018 Option Exercise$1.115,3505,925169,684Aug 16, 2018, 07:00 PM
Bush JenniferGeneral Counsel & SecretaryAug 16, 2018 Option Exercise$1.1112,40013,733293,503Aug 16, 2018, 06:58 PM
CROUCH TAYLORCEO & PresidentJun 25, 2018 Option Exercise$1.4315,49022,194175,034Jun 26, 2018, 05:00 PM
Presnell Sharon CollinsChief Scientific OfficerMay 16, 2018 Option Exercise$1.668,32513,837269,468May 17, 2018, 05:42 PM
KUSSMAN CRAIGChief Financial OfficerMay 16, 2018 Option Exercise$1.6611,72019,480288,763May 17, 2018, 05:41 PM
Gallant PaulGeneral ManagerMay 16, 2018 Option Exercise$1.666,89011,452173,689May 17, 2018, 05:40 PM
Bush JenniferGeneral Counsel & SecretaryMay 16, 2018 Option Exercise$1.669,16015,225235,655May 17, 2018, 05:39 PM
Presnell Sharon CollinsChief Scientific OfficerFeb 16, 2018 Option Exercise$1.099,42010,225277,793Feb 20, 2018, 08:54 AM
KUSSMAN CRAIGChief Financial OfficerFeb 16, 2018 Option Exercise$1.0913,26514,399300,483Feb 20, 2018, 08:53 AM
Gallant PaulGeneral ManagerFeb 16, 2018 Option Exercise$1.097,8208,489180,579Feb 20, 2018, 08:51 AM
Bush JenniferGeneral Counsel & SecretaryFeb 16, 2018 Option Exercise$1.0910,36511,251244,815Feb 20, 2018, 08:50 AM
Murphy KeithFormer affiliate last filingNov 24, 2017 Buy$1.49200,500299,3476,373,673Dec 04, 2017, 09:00 AM
Murphy KeithFormer affiliate last filingNov 22, 2017 Buy$1.50135,000201,9606,173,173Dec 04, 2017, 09:00 AM
Presnell Sharon CollinsChief Scientific OfficerNov 16, 2017 Option Exercise$1.475,8608,615287,213Nov 16, 2017, 07:49 PM
KUSSMAN CRAIGChief Financial OfficerNov 16, 2017 Option Exercise$1.4711,89017,481313,748Nov 16, 2017, 07:48 PM
Gallant PaulGeneral ManagerNov 16, 2017 Option Exercise$1.477,01510,313188,399Nov 16, 2017, 07:47 PM
David EricCSO & EVP Pre-Clinical DevNov 16, 2017 Option Exercise$1.475,6258,270876,609Nov 16, 2017, 07:46 PM
Bush JenniferGeneral Counsel & SecretaryNov 16, 2017 Option Exercise$1.478,90013,085255,180Nov 16, 2017, 07:45 PM
Presnell Sharon CollinsChief Scientific OfficerAug 16, 2017 Option Exercise$2.066,11512,597293,073Aug 17, 2017, 04:52 PM
KUSSMAN CRAIGChief Financial OfficerAug 16, 2017 Option Exercise$2.0626,36254,306325,638Aug 17, 2017, 04:51 PM
Gallant PaulGeneral ManagerAug 16, 2017 Option Exercise$2.067,32415,087195,414Aug 17, 2017, 04:50 PM
David EricCSO & EVP Pre-Clinical DevAug 16, 2017 Option Exercise$2.068,46917,446882,234Aug 17, 2017, 04:49 PM
Bush JenniferGeneral Counsel & SecretaryAug 16, 2017 Option Exercise$2.065,87112,094264,080Aug 17, 2017, 04:48 PM
Gallant PaulGeneral ManagerMay 16, 2017 Option Exercise$2.861,3173,76942,738May 17, 2017, 07:09 PM
David EricCSO & EVP Pre-Clinical DevMay 16, 2017 Option Exercise$2.861,2633,615700,703May 17, 2017, 07:07 PM
Bush JenniferGeneral Counsel & SecretaryMay 16, 2017 Option Exercise$2.861,2353,53544,951May 17, 2017, 07:06 PM
Presnell Sharon CollinsChief Scientific OfficerMay 16, 2017 Option Exercise$2.861,1673,34099,188May 17, 2017, 07:05 PM
Presnell Sharon CollinsChief Scientific OfficerFeb 16, 2017 Option Exercise$2.951,3904,101115,355Feb 21, 2017, 06:02 PM
Murphy KeithChairman, CEO and PresidentFeb 16, 2017 Option Exercise$2.955,74216,9396,038,173Feb 21, 2017, 06:01 PM
Gallant PaulGeneral ManagerFeb 16, 2017 Option Exercise$2.951,3203,89444,055Feb 21, 2017, 06:00 PM
David EricCSO & EVP Pre-Clinical DevFeb 16, 2017 Option Exercise$2.951,3904,101701,966Feb 21, 2017, 05:59 PM
Bush JenniferGeneral Counsel & SecretaryFeb 16, 2017 Option Exercise$2.951,3904,10146,186Feb 21, 2017, 05:57 PM
Murphy KeithChairman, CEO and PresidentFeb 08, 2017 Option Exercise$1.0030,00030,0006,068,915Feb 10, 2017, 06:39 PM
Murphy KeithChairman, CEO and PresidentFeb 09, 2017 Sale$3.6825,00092,0356,043,915Feb 10, 2017, 06:39 PM
Murphy KeithChairman, CEO and PresidentJan 24, 2017 Sale$3.5020,10070,4406,038,915Jan 25, 2017, 04:27 PM
Murphy KeithChairman, CEO and PresidentJan 23, 2017 Sale$3.514,90017,2156,059,015Jan 25, 2017, 04:27 PM
Murphy KeithChairman, CEO and PresidentDec 14, 2016 Sale$3.7250,000185,9556,063,915Dec 15, 2016, 05:35 PM
Presnell Sharon CollinsChief Scientific OfficerNov 16, 2016 Option Exercise$3.261,2103,944116,745Nov 18, 2016, 05:10 PM
Murphy KeithChairman, CEO and PresidentNov 16, 2016 Option Exercise$3.267,20023,4686,113,915Nov 18, 2016, 05:08 PM
Gallant PaulGeneral ManagerNov 16, 2016 Option Exercise$3.261,1603,78145,375Nov 18, 2016, 05:07 PM
David EricCSO & EVP Pre-Clinical DevNov 16, 2016 Option Exercise$3.261,7455,688703,356Nov 18, 2016, 05:06 PM
Bush JenniferGeneral Counsel & SecretaryNov 16, 2016 Option Exercise$3.261,2103,94447,576Nov 18, 2016, 05:04 PM
Murphy KeithChairman, CEO and PresidentSep 16, 2016 Option Exercise$4.001,3945,5766,121,115Sep 20, 2016, 05:02 PM
Presnell Sharon CollinsChief Scientific OfficerAug 19, 2016 Option Exercise$4.001,1094,438117,955Aug 23, 2016, 08:14 PM
Murphy KeithChairman, CEO and PresidentAug 19, 2016 Option Exercise$4.005,12920,5256,122,509Aug 23, 2016, 08:13 PM
Gallant PaulGeneral ManagerAug 19, 2016 Option Exercise$4.009653,86246,535Aug 23, 2016, 08:11 PM
David EricCSO & EVP Pre-Clinical DevAug 19, 2016 Option Exercise$4.001,2054,822705,101Aug 23, 2016, 08:10 PM
Bush JenniferGeneral Counsel & SecretaryAug 19, 2016 Option Exercise$4.001,2144,85848,786Aug 23, 2016, 08:09 PM
David EricCSO & EVP Pre-Clinical DevAug 05, 2016 Sale$4.5520,00091,000706,306Aug 09, 2016, 06:03 PM
Murphy KeithChairman, CEO and PresidentFeb 16, 2016 Option Exercise$2.0424,69050,3685,919,638Feb 18, 2016, 07:01 PM
Baltera Robert Jr.DirectorSep 21, 2015 Sale$4.036,00024,193138,506Sep 23, 2015, 07:22 PM
MICHAELS BARRY DChief Financial OfficerAug 24, 2015 Option Exercise$2.32100,692233,60586,808Aug 24, 2015, 08:31 PM
GLOVER JAMES TDirectorAug 13, 2015 Buy$2.8010,00028,00010,000Aug 13, 2015, 08:12 PM
Murphy KeithChairman, CEO and PresidentAug 12, 2015 Buy$2.5620,00051,1885,944,328Aug 13, 2015, 08:10 PM
Presnell Sharon CollinsEVP, Research & Dev & CTOMar 12, 2015 Option Exercise$0.0850,0004,00074,064Mar 16, 2015, 05:19 PM
Murphy KeithChairman, CEO and PresidentFeb 13, 2015 Option Exercise$6.3428,008177,5715,961,328Feb 18, 2015, 07:04 PM
MICHAELS BARRY DChief Financial OfficerDec 30, 2014 Sale$7.5010,50078,771285,646Dec 31, 2014, 05:05 PM
MICHAELS BARRY DChief Financial OfficerDec 29, 2014 Sale$7.504,50033,750296,146Dec 31, 2014, 05:05 PM
David EricChief Strategy OfficerDec 30, 2014 Sale$7.5616,300123,243681,306Dec 31, 2014, 05:04 PM
David EricChief Strategy OfficerDec 29, 2014 Sale$7.503,70027,754697,706Dec 31, 2014, 05:04 PM
Presnell Sharon CollinsEVP, Research & Dev & CTOOct 06, 2014 Sale$6.1150,000305,47524,064Oct 08, 2014, 08:14 PM
David EricChief Strategy OfficerSep 12, 2014 Sale$7.3030,000218,973701,306Sep 16, 2014, 07:01 PM
MICHAELS BARRY DChief Financial OfficerAug 26, 2014 Option Exercise$2.7318,47450,499488,146Aug 28, 2014, 07:46 PM
MICHAELS BARRY DChief Financial OfficerAug 25, 2014 Option Exercise$7.94102,760815,914469,672Aug 26, 2014, 08:00 PM
Baltera Robert Jr.DirectorJun 06, 2014 Option Exercise$1.003,0003,000144,506Jun 09, 2014, 07:57 PM
Renard MichaelEVP of Commercial OperationsMay 08, 2014 Option Exercise$1.6550,00082,50050,000May 12, 2014, 07:48 PM
Renard MichaelEVP of Commercial OperationsFeb 21, 2014 Option Exercise$1.6510,00016,50010,000Feb 21, 2014, 06:10 PM
Renard MichaelEVP of Commercial OperationsFeb 21, 2014 Sale$10.6510,000106,5000Feb 21, 2014, 06:10 PM
Murphy KeithChairman, CEO and PresidentFeb 19, 2014 Option Exercise$9.8627,307269,2475,997,336Feb 20, 2014, 07:46 PM
Murphy KeithChairman, CEO and PresidentFeb 18, 2014 Sale$9.82100,000982,2205,974,643Feb 20, 2014, 07:46 PM
MICHAELS BARRY DChief Financial OfficerFeb 13, 2014 Option Exercise$2.2522,00049,500572,432Feb 13, 2014, 08:08 PM
Murphy KeithChairman, CEO and PresidentFeb 13, 2014 Option Exercise$9.9227,105268,8826,074,643Feb 13, 2014, 08:07 PM
Renard MichaelEVP of Commercial OperationsJan 29, 2014 Option Exercise$1.6530,00049,50030,000Jan 29, 2014, 08:31 PM
Renard MichaelEVP of Commercial OperationsJan 27, 2014 Option Exercise$1.6510,00016,50010,000Jan 29, 2014, 08:31 PM
Renard MichaelEVP of Commercial OperationsJan 29, 2014 Sale$9.9330,000297,9990Jan 29, 2014, 08:31 PM
Renard MichaelEVP of Commercial OperationsJan 27, 2014 Sale$8.9210,00089,2000Jan 29, 2014, 08:31 PM
Murphy KeithChairman, CEO and PresidentJan 21, 2014 Sale$10.86100,0001,086,2006,101,748Jan 23, 2014, 08:52 PM
MICHAELS BARRY DChief Financial OfficerDec 20, 2013 Option Exercise$2.1047,619100,000550,432Dec 20, 2013, 07:50 PM
MICHAELS BARRY DChief Financial OfficerDec 16, 2013 Sale$9.0785,353774,160502,813Dec 18, 2013, 09:01 PM
Murphy KeithChairman, CEO and PresidentDec 10, 2013 Sale$10.08100,0001,007,5306,201,748Dec 12, 2013, 08:09 PM
Murphy KeithChairman, CEO and PresidentNov 13, 2013 Sale$9.64100,000963,8306,301,748Nov 15, 2013, 08:56 PM
David EricChief Strategy OfficerNov 13, 2013 Sale$10.3916,470171,105731,306Nov 15, 2013, 08:55 PM
Murphy KeithChairman, CEO and PresidentOct 18, 2013 Sale$6.6330,000198,9906,401,748Oct 18, 2013, 07:23 PM
Murphy KeithChairman, CEO and PresidentOct 16, 2013 Sale$5.7670,000403,0466,431,748Oct 18, 2013, 07:23 PM
David EricChief Strategy OfficerOct 10, 2013 Sale$5.663,53019,996747,776Oct 15, 2013, 05:45 PM
David EricChief Strategy OfficerOct 10, 2013 Option Exercise$1.0020,00020,000751,306Oct 15, 2013, 05:45 PM
David EricChief Strategy OfficerOct 07, 2013 Sale$5.8663,000368,953731,306Oct 09, 2013, 06:20 PM
Presnell Sharon CollinsEVP, Research & Dev & CTOOct 02, 2013 Sale$5.6475,000423,22574,064Oct 04, 2013, 06:49 PM
Murphy KeithChairman, CEO and PresidentAug 28, 2013 Option Exercise$5.6054,654306,0626,501,748Aug 30, 2013, 05:07 PM
MICHAELS BARRY DChief Financial OfficerAug 23, 2013 Option Exercise$5.50102,147561,809588,166Aug 26, 2013, 08:57 PM
Presnell Sharon CollinsEVP, Research & Dev & CTOAug 12, 2013 Sale$5.6075,000420,068149,064Aug 14, 2013, 05:57 PM
Murphy KeithChairman, CEO and PresidentFeb 13, 2013 Option Exercise$4.5924,690113,2046,456,402Feb 15, 2013, 04:56 PM
Baltera Robert Jr.DirectorDec 21, 2012 Option Exercise$0.8025,00020,000141,506Dec 21, 2012, 07:37 PM
MICHAELS BARRY DChief Financial OfficerDec 21, 2012 Option Exercise$0.8010,0008,000690,313Dec 21, 2012, 07:35 PM
MICHAELS BARRY DChief Financial OfficerAug 23, 2012 Option Exercise$2.1079,687167,343680,313Aug 24, 2012, 07:21 PM
Presnell Sharon CollinsEVP, Research & Dev & CTOAug 02, 2012 Option Exercise$0.08224,06417,925224,064Aug 08, 2012, 06:48 PM
MICHAELS BARRY DChief Financial OfficerMar 16, 2012 Buy$1.0010,00010,00010,000Jun 05, 2012, 08:26 PM
MICHAELS BARRY DChief Financial OfficerMar 16, 2012 Buy$1.0010,00010,00010,000Mar 20, 2012, 06:14 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Gobel DavidDirector11/15/202331,750
Cohen Douglas JayDirector08/17/20216,738
Cohen Douglas JayDirector08/17/202158,839
Cohen Douglas JayDirector08/17/20216,720
KUSSMAN CRAIGChief Financial Officer08/18/20208,936
CROUCH TAYLORCEO & President08/18/20203,136
Bush JenniferGeneral Counsel & Secretary08/18/20206,204
KUSSMAN CRAIGChief Financial Officer05/18/20209,253
CROUCH TAYLORCEO & President05/18/20203,254
Bush JenniferGeneral Counsel & Secretary05/18/20207,508
KUSSMAN CRAIGChief Financial Officer02/19/20205,462
CROUCH TAYLORCEO & President02/19/20201,931
Bush JenniferGeneral Counsel & Secretary02/19/20204,424
KUSSMAN CRAIGChief Financial Officer11/18/20196,474
CROUCH TAYLORCEO & President11/18/20192,280
Bush JenniferGeneral Counsel & Secretary11/18/20195,255
KUSSMAN CRAIGChief Financial Officer08/16/20194,213
Hughes Steven GeorgeChief Medical Officer08/16/20196,431
Gallant PaulGeneral Manager08/16/20192,713
CROUCH TAYLORCEO & President08/16/20191,514
Bush JenniferGeneral Counsel & Secretary08/16/20193,416
KUSSMAN CRAIGChief Financial Officer05/16/201914,700
Gallant PaulGeneral Manager05/16/20198,996
CROUCH TAYLORCEO & President05/16/20195,301
Bush JenniferGeneral Counsel & Secretary05/16/201911,907
KUSSMAN CRAIGChief Financial Officer02/19/201917,280
Gallant PaulGeneral Manager02/19/201911,094
CROUCH TAYLORCEO & President02/19/20196,037
Bush JenniferGeneral Counsel & Secretary02/19/201914,408
Presnell Sharon CollinsChief Scientific Officer11/16/201811,954
KUSSMAN CRAIGChief Financial Officer11/16/201815,711
Gallant PaulGeneral Manager11/16/201810,086
CROUCH TAYLORCEO & President11/16/20185,486
Bush JenniferGeneral Counsel & Secretary11/16/201812,717
Presnell Sharon CollinsChief Scientific Officer11/08/201850,800
Presnell Sharon CollinsChief Scientific Officer08/16/201812,908
KUSSMAN CRAIGChief Financial Officer08/16/201816,967
Gallant PaulGeneral Manager08/16/201810,892
CROUCH TAYLORCEO & President08/16/20185,925
Bush JenniferGeneral Counsel & Secretary08/16/201813,733
CROUCH TAYLORCEO & President06/25/201822,194
Presnell Sharon CollinsChief Scientific Officer05/16/201813,837
KUSSMAN CRAIGChief Financial Officer05/16/201819,480
Gallant PaulGeneral Manager05/16/201811,452
Bush JenniferGeneral Counsel & Secretary05/16/201815,225
Presnell Sharon CollinsChief Scientific Officer02/16/201810,225
KUSSMAN CRAIGChief Financial Officer02/16/201814,399
Gallant PaulGeneral Manager02/16/20188,489
Bush JenniferGeneral Counsel & Secretary02/16/201811,251
Murphy KeithFormer affiliate last filing11/24/2017299,347
Murphy KeithFormer affiliate last filing11/22/2017201,960
Presnell Sharon CollinsChief Scientific Officer11/16/20178,615
KUSSMAN CRAIGChief Financial Officer11/16/201717,481
Gallant PaulGeneral Manager11/16/201710,313
David EricCSO & EVP Pre-Clinical Dev11/16/20178,270
Bush JenniferGeneral Counsel & Secretary11/16/201713,085
Presnell Sharon CollinsChief Scientific Officer08/16/201712,597
KUSSMAN CRAIGChief Financial Officer08/16/201754,306
Gallant PaulGeneral Manager08/16/201715,087
David EricCSO & EVP Pre-Clinical Dev08/16/201717,446
Bush JenniferGeneral Counsel & Secretary08/16/201712,094
Gallant PaulGeneral Manager05/16/20173,769
David EricCSO & EVP Pre-Clinical Dev05/16/20173,615
Bush JenniferGeneral Counsel & Secretary05/16/20173,535
Presnell Sharon CollinsChief Scientific Officer05/16/20173,340
Presnell Sharon CollinsChief Scientific Officer02/16/20174,101
Murphy KeithChairman, CEO and President02/16/201716,939
Gallant PaulGeneral Manager02/16/20173,894
David EricCSO & EVP Pre-Clinical Dev02/16/20174,101
Bush JenniferGeneral Counsel & Secretary02/16/20174,101
Murphy KeithChairman, CEO and President02/08/201730,000
Murphy KeithChairman, CEO and President02/09/201792,035
Murphy KeithChairman, CEO and President01/24/201770,440
Murphy KeithChairman, CEO and President01/23/201717,215
Murphy KeithChairman, CEO and President12/14/2016185,955
Presnell Sharon CollinsChief Scientific Officer11/16/20163,944
Murphy KeithChairman, CEO and President11/16/201623,468
Gallant PaulGeneral Manager11/16/20163,781
David EricCSO & EVP Pre-Clinical Dev11/16/20165,688
Bush JenniferGeneral Counsel & Secretary11/16/20163,944
Murphy KeithChairman, CEO and President09/16/20165,576
Presnell Sharon CollinsChief Scientific Officer08/19/20164,438
Murphy KeithChairman, CEO and President08/19/201620,525
Gallant PaulGeneral Manager08/19/20163,862
David EricCSO & EVP Pre-Clinical Dev08/19/20164,822
Bush JenniferGeneral Counsel & Secretary08/19/20164,858
David EricCSO & EVP Pre-Clinical Dev08/05/201691,000
Murphy KeithChairman, CEO and President02/16/201650,368
Baltera Robert Jr.Director09/21/201524,193
MICHAELS BARRY DChief Financial Officer08/24/2015233,605
GLOVER JAMES TDirector08/13/201528,000
Murphy KeithChairman, CEO and President08/12/201551,188
Presnell Sharon CollinsEVP, Research & Dev & CTO03/12/20154,000
Murphy KeithChairman, CEO and President02/13/2015177,571
MICHAELS BARRY DChief Financial Officer12/30/201478,771
MICHAELS BARRY DChief Financial Officer12/29/201433,750
David EricChief Strategy Officer12/30/2014123,243
David EricChief Strategy Officer12/29/201427,754
Presnell Sharon CollinsEVP, Research & Dev & CTO10/06/2014305,475
David EricChief Strategy Officer09/12/2014218,973
MICHAELS BARRY DChief Financial Officer08/26/201450,499
MICHAELS BARRY DChief Financial Officer08/25/2014815,914
Baltera Robert Jr.Director06/06/20143,000
Renard MichaelEVP of Commercial Operations05/08/201482,500
Renard MichaelEVP of Commercial Operations02/21/201416,500
Renard MichaelEVP of Commercial Operations02/21/2014106,500
Murphy KeithChairman, CEO and President02/19/2014269,247
Murphy KeithChairman, CEO and President02/18/2014982,220
MICHAELS BARRY DChief Financial Officer02/13/201449,500
Murphy KeithChairman, CEO and President02/13/2014268,882
Renard MichaelEVP of Commercial Operations01/29/201449,500
Renard MichaelEVP of Commercial Operations01/27/201416,500
Renard MichaelEVP of Commercial Operations01/29/2014297,999
Renard MichaelEVP of Commercial Operations01/27/201489,200
Murphy KeithChairman, CEO and President01/21/20141,086,200
MICHAELS BARRY DChief Financial Officer12/20/2013100,000
MICHAELS BARRY DChief Financial Officer12/16/2013774,160
Murphy KeithChairman, CEO and President12/10/20131,007,530
Murphy KeithChairman, CEO and President11/13/2013963,830
David EricChief Strategy Officer11/13/2013171,105
Murphy KeithChairman, CEO and President10/18/2013198,990
Murphy KeithChairman, CEO and President10/16/2013403,046
David EricChief Strategy Officer10/10/201319,996
David EricChief Strategy Officer10/10/201320,000
David EricChief Strategy Officer10/07/2013368,953
Presnell Sharon CollinsEVP, Research & Dev & CTO10/02/2013423,225
Murphy KeithChairman, CEO and President08/28/2013306,062
MICHAELS BARRY DChief Financial Officer08/23/2013561,809
Presnell Sharon CollinsEVP, Research & Dev & CTO08/12/2013420,068
Murphy KeithChairman, CEO and President02/13/2013113,204
Baltera Robert Jr.Director12/21/201220,000
MICHAELS BARRY DChief Financial Officer12/21/20128,000
MICHAELS BARRY DChief Financial Officer08/23/2012167,343
Presnell Sharon CollinsEVP, Research & Dev & CTO08/02/201217,925
MICHAELS BARRY DChief Financial Officer03/16/201210,000
MICHAELS BARRY DChief Financial Officer03/16/201210,000
Load More Insider Transactions
FUNDS WITH A POSITION IN ORGANOVO HOLDINGS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.142,2080%-3.6%Other
RENAISSANCE TECHNOLOGIES LLC97,7870.00016%-3.65%Other
GEODE CAPITAL MANAGEMENT, LLC74,9100.00001%1.02%Other
CHANGE IN SHARES OUTSTANDING FOR ORGANOVO HOLDINGS INC
STOCK BUYBACKS FOR ORGANOVO HOLDINGS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
10.00%
1Q
03/31/2024
09/30/2023
15.01%
2Q
03/31/2024
06/30/2023
15.03%
3Q
03/31/2024
03/31/2023
15.05%
4Q
03/31/2024
12/31/2022
15.07%
5Q
03/31/2024
09/30/2022
15.09%
6Q
03/31/2024
06/30/2022
15.11%
7Q
03/31/2024
03/31/2022
15.18%
8Q
03/31/2024
12/31/2021
15.18%
9Q
03/31/2024
09/30/2021
15.18%
10Q
03/31/2024
06/30/2021
15.30%
11Q
03/31/2024
03/31/2021
31.03%
12Q
03/31/2024
12/31/2020
46.18%
13Q
03/31/2024
09/30/2020
52.73%
14Q
03/31/2024
06/30/2020
53.57%
15Q
03/31/2024
03/31/2020
53.65%
16Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
10.00%
1Q
09/30/2023
15.01%
2Q
06/30/2023
15.03%
3Q
03/31/2023
15.05%
4Q
12/31/2022
15.07%
5Q
09/30/2022
15.09%
6Q
06/30/2022
15.11%
7Q
03/31/2022
15.18%
8Q
12/31/2021
15.18%
9Q
09/30/2021
15.18%
10Q
06/30/2021
15.30%
11Q
03/31/2021
31.03%
12Q
12/31/2020
46.18%
13Q
09/30/2020
52.73%
14Q
06/30/2020
53.57%
15Q
03/31/2020
53.65%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ORGANOVO HOLDINGS INC
LOADING...